EphA2 as a target for ovarian cancer therapy
Author:
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14728222.9.6.1179
Reference65 articles.
1. Eph Receptors and Ligands Comprise Two Major Specificity Subclasses and Are Reciprocally Compartmentalized during Embryogenesis
2. Crystal structure of an Eph receptor–ephrin complex
3. Effects of overexpression of ephrin-B2 on tumour growth in human colorectal cancer
4. Expression of Ephb2 and Ephb4 in breast carcinoma
5. EphB receptor activity suppresses colorectal cancer progression
Cited by 87 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prognostic and therapeutic value of the Eph/Ephrin signaling pathway in pancreatic cancer explored based on bioinformatics;Scientific Reports;2024-07-31
2. Unlocking the potential of nanocarrier-mediated mRNA delivery across diverse biomedical frontiers: A comprehensive review;International Journal of Biological Macromolecules;2024-05
3. The Clinical Relevance of the EPH/Ephrin Signaling Pathway in Pediatric Solid and Hematologic Malignancies;International Journal of Molecular Sciences;2024-03-29
4. Development of a novel EphA2-targeting radioligand for SPECT imaging in different tumor models;European Journal of Medicinal Chemistry;2024-02
5. EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer;International Journal of Molecular Sciences;2024-01-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3